Dipayan Chaudhuri
No Rating Available
(Learn About Our Rating System)

Dipayan Chaudhuri, MD, PhD

Languages spoken: Spanish, English

Clinical Locations

Primary Location

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Dipayan Chaudhuri, MD, PhD is the Section Chief for General Cardiology, and the Medical Director of the Cardiovascular Medicine Unit and Cardiovascular Acute Care Unit at the University of Utah Hospital. His clinical interests are in the care for patients admitted to the hospital with primary cardiovascular problems, including myocardial infarction, atrial fibrillation, heart failure, and other common cardiac disorders. He is also a Principal Investigator at the Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI) on the Health Sciences Campus. His NIH-funded research focuses on changes in metabolism during heart failure.

Dr. Dipayan Chaudhuri earned his medical and graduate degrees at the Johns Hopkins University School of Medicine. He then completed a residency in internal medicine at the University of California, San Francisco, and subsequently a clinical fellowship in cardiovascular diseases at the Massachusetts General Hospital. Concurrently with his clinical fellowship, he completed a postdoctoral research fellowship at Massachusetts General Hospital and Boston Children’s Hospital. Dr. Chaudhuri joined the faculty of the Cardiovascular Medicine Division at the University of Utah in 2016.

Specialties

Board Certification

National Board of Echocardiography
American Board of Internal Medicine (Sub: Cardiovascular Disease)

Dipayan Chaudhuri, MD, PhD is the Section Chief for General Cardiology, and the Medical Director of the Cardiovascular Medicine Unit and Cardiovascular Acute Care Unit at the University of Utah Hospital. His clinical interests are in the care for patients admitted to the hospital with primary cardiovascular problems, including myocardial infarction, atrial fibrillation, heart failure, and other common cardiac disorders. He is also a Principal Investigator at the Nora Eccles Harrison Cardiovascular Research and Training Institute (CVRTI) on the Health Sciences Campus. His NIH-funded research focuses on changes in metabolism during heart failure.

Dr. Dipayan Chaudhuri earned his medical and graduate degrees at the Johns Hopkins University School of Medicine. He then completed a residency in internal medicine at the University of California, San Francisco, and subsequently a clinical fellowship in cardiovascular diseases at the Massachusetts General Hospital. Concurrently with his clinical fellowship, he completed a postdoctoral research fellowship at Massachusetts General Hospital and Boston Children’s Hospital. Dr. Chaudhuri joined the faculty of the Cardiovascular Medicine Division at the University of Utah in 2016.

Board Certification and Academic Information

Academic Departments Biochemistry -Adjunct Associate Professor
Internal Medicine -Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification
National Board of Echocardiography
American Board of Internal Medicine (Sub: Cardiovascular Disease)

Education history

Undergraduate Biology, Philosophy - Cornell University B.A.
Professional Medical Medicine, Neuroscience - Johns Hopkins University School of Medicine M.D., Ph.D.
Internship Internal Medicine - University of California, San Francisco Intern
Residency Internal Medicine, ABIM Research Pathway - University of California, San Francisco Resident
Fellowship Cardiovascular Diseases - Massachusetts General Hospital Clinical Fellow
Research Fellow Cardiovascular Research Center - Massachusetts General Hospital Research Fellow
Research Fellow Cardiology - Boston Children¿s Hospital Research Fellow

Selected Publications

Journal Article

  1. Eberhardt DR, Rekate EC, Masini YB, Duron HE, Mollinedo D, Velarde AM, Stucki D, Price T, Lee SHJ, Balderas E, Rai NK, Bratt AR, Balynas AM, Stubben CJ, Bia R, Maity S, Hartel N, Yin X, Corbin A, Kumari A, Nguyen DM, Shimura D, Nguyen VD, Vinod V, Chowdhury KH, Verdeguer F, Zvick J, Mimche PN, Boudina S, Drakos SG, Aromolaran AS, Franklin S, Garg V, Shaw RM, Holland WL, Summers SA, Pezzolesi MG, Rutter J, Evason KJ, Chaudhuri (2026). Excessive Ca(2+)-dependent ER-mitochondrial contact stabilization by EFHD1 drives liver injury. bioRxiv,
  2. Mia S, Siokatas G, Sidiropoulou R, Hoffman M, Fragkiadakis K, Markopoulou E, Elesawy MI, Roy R, Blair S, Kuwabara Y, Rapushi E, Chaudhuri D, Makarewich CA, Gao E, Koch WJ, Schilling JD, Molkentin JD, Marketou M, Drosatos (2025). Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling. Cell reports. Medicine, 102125.
  3. Rai NK, Eberhardt DR, Balynas AM, MacEwen MJS, Bratt AR, Sancak Y, Chaudhuri (2025). Mechanism of MCUB-Dependent Inhibition of Mitochondrial Calcium Uptake. Journal of cellular physiology, 240(4), e70033.
  4. Ajanel A, Andrianova I, Kowalczyk M, Menéndez-Pérez J, Bhatt SR, Portier I, Boone TC, Ballard-Kordeliski A, Kosaka Y, Chaudhuri D, Paul DS, Bergmeier W, Denorme F, Campbell R (2025). Mitochondrial Calcium Uniporter Regulates ITAM-Dependent Platelet Activation. Circulation research, 137(4), 474-492.
  5. Barr RG, Lima JAC, Prince MR, Ambale Venkatesh B, Abraham T, Agarwal PP, Arora G, Balasubramanian A, Barjaktarevic I, Bello NA, Bluemke DA, Budoff MJ, Carr JC, Chaudhuri D, Cooper CB, Couper D, Finn JP, Freed BH, Han MK, Hansel NN, Hsu JJ, Kitzman DW, Krishnan JA, LaBounty TM, Lee YJ, Liu J, Lloyd SG, Markl M, Mukherjee M, Beussink-Nelson L, Ohar J, Ortega VE, Paine R 3rd, Peters SP, Schroeder JD, Shen W, Shepshelovich D, Sun Y, Vogel-Claussen J, Watson KE, Wells JM, Wieben O, Woodruff PG, Shah S (2025). SPIROMICS HF: Rationale, Design, and Reproducibility of Measures. Circulation. Heart failure, e012833.
  6. Mitchell G, Javan H, Nickel I, Valdez S, Palatinus JA, Szulik M, Eberhardt D, Franklin S, Chaudhuri D, Skliar M, Ripoll CV, Pierce J, Selzman C (2025). Intravenous acellular human amniotic fluid prevents ischemic cardiac remodeling. Scientific reports, 15(1), 44725.
  7. Visker JR, Cluntun AA, Velasco-Silva JN, Eberhardt DR, Cedeno-Rosario L, Shankar TS, Hamouche R, Ling J, Kwak H, Hillas JY, Aist I, Tseliou E, Navankasattusas S, Chaudhuri D, Ducker GS, Drakos SG, Rutter (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI insight, 9(17),
  8. Atomwise AIMS Progra (2024). AI is a viable alternative to high throughput screening: a 318-target study. Scientific reports, 14(1), 7526.
  9. Cluntun AA, Visker JR, Velasco-Silva JN, Lang MJ, Cedeño-Rosario L, Shankar TS, Hamouche R, Ling J, Kim JE, Toshniwal AG, Low HK, Cunningham CN, Carrington J, Catrow JL, Pearce Q, Jeong MY, Bott AJ, Narbona-Pérez ÁJ, Stanley CE, Li Q, Eberhardt DR, Morgan JT, Yadav T, Wells CE, Ramadurai DKA, Swiatek WI, Chaudhuri D, Rothstein JD, Muoio DM, Paulo JA, Gygi SP, Baker SA, Navankasattusas S, Cox JE, Funai K, Drakos SG, Rutter J, Ducker G (2024). Direct mitochondrial import of lactate supports resilient carbohydrate oxidation. bioRxiv,
  10. Johnson JM, Peterlin AD, Balderas E, Sustarsic EG, Maschek JA, Lang MJ, Jara-Ramos A, Panic V, Morgan JT, Villanueva CJ, Sanchez A, Rutter J, Lodhi IJ, Cox JE, Fisher-Wellman KH, Chaudhuri D, Gerhart-Hines Z, Funai (2023). Mitochondrial phosphatidylethanolamine modulates UCP1 to promote brown adipose thermogenesis. Science advances, 9(8), eade7864.
  11. Szulik MW, Valdez S, Walsh M, Davis K, Bia R, Horiuchi E, O'Very S, Laxman AK, Sandaklie-Nicolova L, Eberhardt DR, Durrant JR, Sheikh H, Hickenlooper S, Creed M, Brady C, Miller M, Wang L, Garcia-Llana J, Tracy C, Drakos SG, Funai K, Chaudhuri D, Boudina S, Franklin (2023). SMYD1a protects the heart from ischemic injury by regulating OPA1-mediated cristae remodeling and supercomplex formation. Basic research in cardiology, 118(1), 20.
  12. Balderas E, Lee SHJ, Shankar TS, Yin X, Balynas AM, Kyriakopoulos CP, Selzman CH, Drakos SG, Chaudhuri (2023). Mitochondria possess a large, non-selective ionic current that is enhanced during cardiac injury. bioRxiv,
  13. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri (2022). Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nature communications, 13(1), 2769.

Review

  1. Eberhardt DR, Chaudhuri (2026). Mitochondrial Calcium Signaling in Hepatocyte Health and Disease. Cold Spring Harbor perspectives in biology, 18(3),
  2. Balderas E, Lee SHJ, Rai NK, Mollinedo DM, Duron HE, Chaudhuri (2024). Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease. Physiology (Bethesda, Md.), 39(5), 0.
  3. Lee SH, Duron HE, Chaudhuri (2023). Beyond the TCA cycle: new insights into mitochondrial calcium regulation of oxidative phosphorylation. Biochemical Society transactions, 51(4), 1661-1673.

Book Chapter

  1. Balderas E, Sommakia S, Eberhardt D, Lee S, Chaudhuri (2023). The structural era of the mitochondrial calcium uniporter. 12-1 to 12-22.

Editorial

  1. Balderas E, Chaudhuri (2023). Absence (of the uniporter) makes the heart grow fonder: The cardiac response to injury adapts after prolonged EMRE inhibition. Journal of molecular and cellular cardiology, 181, 31-32.